Today, FreedomWorks Foundation submitted a formal comment to President Biden’s Commission on the Supreme Court of the United States opposing its consideration of ‘reforms’ that would fundamentally change the Court and turn it into a weapon of partisan politics.

The Federal Trade Commission (FTC or Commission) has launched a task force to review and update analyses of pharmaceutical mergers. The FTC’s task force is composed of the Canadian Competition Bureau, the European Commission Directorate General for Competition, the U.K.’s Competition and Markets Authority, the U.S. Department of Justice (DOJ) Antitrust Division, and Offices of State Attorneys General. The task force seeks input from the public to inform their review. Comments are due June 25, 2021.

On behalf of our activist community, I urge you to contact your representative and ask him or her to support the Lessening Regulatory Costs and Establishing a Federal Regulatory Budget Act, H.R. 968. Introduced by Rep. Ted Budd (R-N.C.), the Lessening Regulatory Costs and Establishing a Federal Regulatory Budget Act would ensure that for every significant regulation created two are eliminated and that the total cost of regulations does not increase.

On behalf of FreedomWorks’ activist community, I urge you to contact your senators and ask them to cosponsor the Regulations from the Executive in Need of Scrutiny (REINS) Act, S. 68, if they haven’t already done so. Introduced by Sen. Rand Paul (R-Ky.), the REINS Act would reaffirm the legislative branch’s Article I authority by requiring that economically significant rules be approved through a joint resolution of Congress before they can take effect.

With some conservatives flirting with expanding antitrust enforcement to punish Silicon Valley, they risk playing into Senator Amy Klobuchar’s radical vision for government control.